This is a preview of subscription content, log in via an institution to check access.
References
A. G. Sanadze, B. M. Gekht, D. V. Sidnev, et al., “Antibodies to acetylcholine receptors in the diagnosis of myasthenia and other forms associated with pathology of neuromuscular transmission,” Nevrol. Zh., 8, Supplement 1, 19–21 (2003).
D. V. Sidnev, A. G. Sanadze, T. V. Davydova, et al., “Antibodies to muscles (antititin antibodies in the diagnosis of myasthenia associated with thymoma,” Nevrol. Zh., 8, Supplement 1, 21–23 (2003).
J. Aarli, G. Skeie, A. Mygland, and N. Gilhus, “Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significance,” Ann. N.Y. Acad. Sci., 841, 505–515 (1998).
R. J. Barohn, “How to administer the quantitative myasthenia test,” Myasthenia Gravis Foundation of America, Inc. (1966).
R. J. Barohn, D. McIntire, L. Herbelin, et al., “Reliability testing of the quantitative myasthenia gravis score,” Ann. N.Y. Acad. Sci., 841, 769–772 (1998).
D. B. Drachman, R. N. Adams, L. F. Josifek, and S. G. Self, “Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis,” New Engl. J. Med., 307, 769–773 (1982).
A. Engel, “The investigation of congenital myasthenic syndromes,” Ann. N.Y. Acad. Sci., 681, 425–435 (1993).
C. Gotti, B. Balestra, R. Mantegazza, et al., “Detection of antibody sub-populations in myasthenia gravis using a non-radioactive new enzyme immunoassay,” Muscle & Nerve, 20, 800–808 (1997).
P. F. Kennel, J. T. Cilquin, S. Braun, et al., “Myasthenia gravis: comparative autoantibody assays using human muscle, TE671-and glucocorticoid-treated TE671 cells as sources of antigen,” Clin. Immunopathol., 74, 293–296 (1995).
B. Lang, J. Newsom-Davis, C. Prior, and D. Wray, “Antibody specificities in Lambert-Eaton myasthenic syndrome,” Ann. N.Y. Acad. Sci., 681, 382–393 (1994).
B. Lang and J. Newsom-Davis, “Immunopathology of the Lambert-Eaton myasthenic syndrome,” in: Springer Seminars in Immunopathology, 17, 3–15 (1995).
V. A. Lennon, Th. J. Kyrzer, G. E. Griesmann, et al., “Calcium channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes,” New Engl. J. Med., 332, 1467–1474 (1995).
V. A. Lennon, L. G. Ermilov, J. H. Szurszewski, and S. Vernino, “Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease,” J. Clin. Invest., 111, 907–913 (2003).
J. Lindstrom, D. Shelton, and Y. Fujii, “Myasthenia gravis,” Adv. Immunol., 42, 233–284 (1988).
J. Lindstrom, “Nicotinic acetylcholine receptors in health and disease,” Molecular Neurobiology, 2, 193–222 (1997).
M. Motomura, I. Johnston, B. Lang, et al., “An improved diagnostic assay for Lambert-Eaton myasthenic syndrome,” J. Neurol. Neurosurg. Psychiat., 58, 85–87 (1995).
S. J. Oh and E. Sher, “MG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence,” Clin. Neurophysiol., 116, No. 5, 1167–1171 (2005).
J. O’Neill, N. Murray, and J. Newsom-Davis, “The Lambert-Eaton myasthenic syndrome. A review of 50-cases,” Brain, 111, 577–596 (1988).
A. Vincent, P. J. Whiting, M. Schluep, et al., “Antibody heterogeneity and specificity in myasthenia gravis,” Ann. N.Y. Acad. Sci., 505, 106–120 (1987).
S. Vernino and V. A. Lennon, “Autoantibody profiles and neurological correlations of thymoma,” Clin. Cancer Res., 10, 7270–7275 (2004).
R. Voltz, R. Hohlfield, A. Faten-Mothadam, et al., “Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671,” Neurology, 41, 1836–1838 (1991).
N. Willcox, M. Schluep, M. A. Ritter, et al., “Myasthenic and nonmyasthenic thymoma: an expansion of a minor cortical epithelial cell subset?” Amer. J. Pathol., 127, 447–460 (1987).
N. Willcox, “Myasthenia gravis,” Curr. Opin. Immunol., 5, 910–917 (1993).
Author information
Authors and Affiliations
Additional information
__________
Translated from Zhurnal Nevrologii i Psikhiatrii imeni. S. S. Korsakova, Vol. 106, No. 1, pp. 53–55, January, 2006.
Rights and permissions
About this article
Cite this article
Sidnev, D.V., Karganov, M.Y., Shcherbakova, N.I. et al. Antibodies to acetylcholine receptors in patients with different clinical forms of myasthenia and Lambert-Eaton myasthenic syndrome. Neurosci Behav Physiol 37, 129–131 (2007). https://doi.org/10.1007/s11055-007-0160-y
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11055-007-0160-y